Isoprenaline (INN)
Isoprenaline (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties
Isoproterenol
Isoprenaline is a secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders. It has a role as a beta-adrenergic agonist, a bronchodilator agent, a sympathomimetic agent and a cardiotonic drug. It is a member of catechols, a secondary alcohol and a secondary amino compound. — ChEBI
- IUPAC name
- 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol
- Molecular formula
- C11H17NO3
- Molecular weight
- 211.26 g/mol
- Exact mass
- 211.12084340 Da
- XLogP3
- -0.6
- Topological polar surface area
- 72.7 Ų
- Hydrogen-bond donors
- 4
- Hydrogen-bond acceptors
- 4
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Isoprenaline (INN)
Chemical / IUPAC name
1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-
Regulatory information
Key data
Related records for Isoprenaline (INN)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Rauwolfia serpentia L., alkaloids and their salts
Nalorphine (INN), its salts and ethers
Adonis vernalis L. and its preparations
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first…
Aconitine (principal alkaloid of Aconitum napellus L.) and its salts
Aniline, its salts and its halogenated and sulphonated derivatives
Aconitum napellus L. (leaves, roots and galenical preparations)
What Annex II means for Isoprenaline (INN)
Isoprenaline (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Isoprenaline (INN)
This page summarizes one Annex II record for Isoprenaline (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Isoprenaline (INN), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Isoprenaline (INN) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Isoprenaline (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II